Researching COVID to enhance recovery (RECOVER) tissue pathology study protocol: Rationale, objectives, and design
PLOS ONE · 10.01.2024 · 19 (1) · e0285645
DOI: 10.1371/journal.pone.0285645 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, online erschienen am 10.01.2024. Verfasst von Andrea B Troxel und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Importance SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or organ dysfunction after the acute phase of infection, termed Post-Acute Sequelae of SARS-CoV-2 (PASC), or long COVID. The characteristics, prevalence, trajectory and mechanisms of PASC are poorly understood. The objectives of the Researching COVID to Enhance Recovery (RECOVER) tissue pathology study (RECOVER-Pathology) are to: (1) characterize prevalence and types of organ injury/disease and pathology occurring with PASC; (2) characterize the association of pathologic findings with clinical and other characteristics; (3) define the pathophysiology and mechanisms of PASC, and possible mediation via viral persistence; and (4) establish a post-mortem tissue biobank and post-mortem brain imaging biorepository.
Methods
RECOVER-Pathology is a cross-sectional study of decedents dying at least 15 days following initial SARS-CoV-2 infection. Eligible decedents must meet WHO criteria for suspected, probable, or confirmed infection and must be aged 18 years or more at the time of death. Enrollment occurs at 7 sites in four U.S. states and Washington, DC. Comprehensive autopsies are conducted according to a standardized protocol within 24 hours of death; tissue samples are sent to the PASC Biorepository for later analyses. Data on clinical history are collected from the medical records and/or next of kin. The primary study outcomes include an array of pathologic features organized by organ system. Causal inference methods will be employed to investigate associations between risk factors and pathologic outcomes.
Discussion
RECOVER-Pathology is the largest autopsy study addressing PASC among US adults. Results of this study are intended to elucidate mechanisms of organ injury and disease and enhance our understanding of the pathophysiology of PASC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States of America.
- Department of Biostatistics, Massachusetts General Hospital, Boston, MA, United States of America.
- Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN, United States of America.
- Department of Pathology, Molecular and Cell-Based Medicine, Mount Sinai Health System, New York, NY, United States of America.
- Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM, United States of America.
- Department of Pathology, CVPath Institute, Gaithersburg, MD, United States of America.
ORCID-Profile: Marie-Abele C Bind, Thomas J Flotte, Alan C Seifert, Stephanie Hafner, Brittany B Vallejos, Phoebe Del Boccio, Chloe E Young, Deepshikha Kewlani, Brendan Parent, Teresa C Cato, Daniel J Shinnick, Lauren E Stiles, Moira L Paskett
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- Foundation for the National Institutes of Health
Zitieren
APA
Troxel, A. B., Bind, M. C., Flotte, T. J., Cordon-Cardo, C., Decker, L. A., Finn, A. V., Padera, R. F., Reichard, R. R., Stone, J. R., Adolphi, N. L., Casimero, F. V. C., Crary, J. F., Elifritz, J., Faustin, A., Ghosh, S. K. B., Krausert, A., Martinez-Lage, M., Melamed, J., Mitchell, R. A., …, & RECOVER Initiative Autopsy Group (2024). Researching COVID to enhance recovery (RECOVER) tissue pathology study protocol: Rationale, objectives, and design. PLOS ONE, 19(1), e0285645. https://doi.org/10.1371/journal.pone.0285645
Vancouver
Troxel AB, Bind MC, Flotte TJ, Cordon-Cardo C, Decker LA, Finn AV, et al. Researching COVID to enhance recovery (RECOVER) tissue pathology study protocol: Rationale, objectives, and design. PLOS ONE. 2024;19(1):e0285645. doi:10.1371/journal.pone.0285645
BibTeX
@article{Troxel2024,
author = {Troxel, Andrea B and Bind, Marie-Abele C and Flotte, Thomas J and Cordon-Cardo, Carlos and Decker, Lauren A and Finn, Aloke V and Padera, Robert F and Reichard, R Ross and Stone, James R and Adolphi, Natalie L and Casimero, Faye Victoria C and Crary, John F and Elifritz, Jamie and Faustin, Arline and Ghosh, Saikat Kumar B and Krausert, Amanda and Martinez-Lage, Maria and Melamed, Jonathan and Mitchell, Roger A and Sampson, Barbara A and Seifert, Alan C and Simsir, Aylin and Adams, Cheryle and Haasnoot, Stephanie and Hafner, Stephanie and Siciliano, Michelle A and Vallejos, Brittany B and Del Boccio, Phoebe and Lamendola-Essel, Michelle F and Young, Chloe E and Kewlani, Deepshikha and Akinbo, Precious A and Parent, Brendan and Chung, Alicia and Cato, Teresa C and Mudumbi, Praveen C and Esquenazi-Karonika, Shari and Wood, Marion J and Chan, James and Monteiro, Jonathan and Shinnick, Daniel J and Thaweethai, Tanayott and Nguyen, Amber N and Fitzgerald, Megan L and Perlowski, Alice A and Stiles, Lauren E and Paskett, Moira L and Katz, Stuart D and Foulkes, Andrea S and RECOVER Initiative Autopsy Group, RECOVER Initiative Autopsy Group},
title = {Researching COVID to enhance recovery (RECOVER) tissue pathology study protocol: Rationale, objectives, and design},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {1},
pages = {e0285645},
doi = {10.1371/journal.pone.0285645}
}
EUVIMED